Medtronic (MDT) reached $83.87 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.

zacks.com - 2026-07-10 18:51:12

I initiate coverage on Medtronic, highlighting its status as a leading medtech name with premium margins. MDT offers an attractive diversification opportunity, combining consistent performance with accelerated revenue growth. The stock trades at undervalued levels, supporting a long-term bullish thesis and a defensive investment approach.

seekingalpha.com - 2026-07-10 11:16:35

Medtronic plc is rated buy with a $92 price target, reflecting conservative fiscal 2027 guidance and resilient growth platforms. Fiscal 2026 delivered $36.4B in revenue, the strongest growth in a decade, led by Cardiovascular and ablation solutions outpacing market rates. Guidance for fiscal 2027 excludes potential catalysts—MiniMed separation, tariff refunds, and Blackstone payment relief—implying room for upside surprises.

seekingalpha.com - 2026-07-10 06:32:24

Medtronic is a dividend aristocrat with a near-decade high yield, making it an attractive long-term income opportunity. The company is experiencing strong revenue growth, driven by its leading positions in cardiovascular and neuroscience medical devices. While current free cash flow payout ratios are sustainable, investors should monitor future dividend growth rates closely.

seekingalpha.com - 2026-07-09 08:32:23

AbbVie is hitting its stride now that it has transitioned past Humira's patent expiration. Medtronic is a steady dividend payer with some intriguing upside in robotics-assisted surgery.

fool.com - 2026-07-07 10:45:00

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-07-03 12:31:08

Medtronic (MDT) reached $78.23 at the closing of the latest trading day, reflecting a -3.34% change compared to its last close.

zacks.com - 2026-06-30 18:51:09

On June 30, 2026, Medtronic PLC (MDT) shares fell 3.3% today, bringing the current price to $78.23. The stock has traded between $73.31 and $106.33 over the pas

gurufocus.com - 2026-06-30 17:12:00

Globus Medical or Medtronic? See why Globus Medical's stronger growth, innovation and analyst upside may give it the edge despite a richer valuation.

zacks.com - 2026-06-29 14:41:17

These healthcare leaders have encountered challenges in recent years. However, they are slowly improving their businesses, partly through innovation.

fool.com - 2026-06-23 16:30:00

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

zacks.com - 2026-06-22 10:31:07

Medtronic offers high growth potential in addition to discounted valuation.

barrons.com - 2026-06-18 07:01:00

These stocks pay between 2.9% and 5.2% in dividends. Their low beta values indicate that they don't follow the market too closely.

fool.com - 2026-06-17 11:00:00

Investors need to pay close attention to MDT stock based on the movements in the options market lately.

zacks.com - 2026-06-16 11:26:08

These three healthcare leaders are slowly overcoming recent obstacles. They have strong dividend track records and the means to maintain healthy dividend growth.

fool.com - 2026-06-16 06:15:00

For an investor in their 50s or 60s who is finished chasing trends, Medtronic (NYSE:MDT | MDT Price Prediction) is a stock worth owning for decades because it pairs inelastic demand for medical devices with a 49th consecutive year of dividend increases.

247wallst.com - 2026-06-14 10:57:33

In this article series, I summarize dividend announcements of the past week. Six stocks in my database announced dividend increases, including one stock I own, and one declared a special dividend. W. R. Berkley stands out with an 11.1% dividend increase, a 50¢ special dividend, and the highest quality score this week. Medtronic offers the most value, trading 9% below fair value, but its dividend growth is modest at 1.4%.

seekingalpha.com - 2026-06-13 03:30:57

Acquisition delivers simplicity and access, supporting physicians across the full procedural workflow GALWAY, Ireland, June 12, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has completed its acquisition of Scientia Vascular, a privately-held medical device company in Salt Lake City. The acquisition is valued at $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition.

prnewswire.com - 2026-06-12 11:00:00

MDT is betting on ablation, robotics and hypertension therapies as next growth drivers, but tariffs, FX and pricing pressures cloud near-term upside.

zacks.com - 2026-06-11 09:51:19

MDT trades at about 14x forward earnings with a 3.5% yield as fiscal 2027 guidance points to steady growth, but margins face tariffs and mix pressure.

zacks.com - 2026-06-10 10:21:04

Even the hottest AI stocks won't win forever. Diversification is the key to long-term wealth.

fool.com - 2026-06-10 04:05:00

Tech stocks are pulling back, and healthcare is surging.

investopedia.com - 2026-06-09 18:06:29

Medtronic plc is a sleepy Dividend Aristocrat with the potential for dividend growth to reaccelerate in the next 12 to 24 months. MDT beat the analyst consensus for revenue and non-GAAP EPS in Q4 2026, with the highest annual revenue growth in 10 years. Medtronic sports an A S&P credit rating with a stable outlook.

seekingalpha.com - 2026-06-08 17:49:28

Medtronic recently reported strong results, highlighting impressive growth.

fool.com - 2026-06-08 10:30:00

Medtronic's Hugo robotic-assisted surgery platform is approved in the U.S. for urologic procedures, and has more applications pending. Intuitive Surgical's da Vinci is the market's flagship platform, and will be difficult to overtake at this point.

fool.com - 2026-06-08 07:21:00

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.

seekingalpha.com - 2026-06-05 18:19:56

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

zacks.com - 2026-06-05 10:31:11

Lowe's, Medtronic, and UnitedHealth Group have been solid dividend growth stocks over the years. They offer above-average payouts and their valuations are also attractive.

fool.com - 2026-06-05 08:00:00

On Wednesday, Medtronic plc (NYSE:MDT) reported fourth-quarter revenue that exceeded Wall Street expectations, supported by strong growth in its Cardiovascular and Diabetes businesses.

benzinga.com - 2026-06-04 14:53:22

Medtronic's NYSE: MDT primary catalyst as mid-year approaches is that headwinds are not impairing results as much as feared. Rising costs, margin compression, and general uncertainty linked to macroeconomic headwinds were reflected in the company's June 3 earnings results, but the results were inherently strong and expected to remain so.

marketbeat.com - 2026-06-04 13:10:27

MDT touts FY26 as a turning point, keeps FY27 growth targets high, and spotlights CAS and new platforms as investors press on tariffs and TAVR.

zacks.com - 2026-06-04 05:40:29

Medtronic plc (MDT) Q4 2026 Earnings Call Transcript

seekingalpha.com - 2026-06-03 15:32:01

Revenue: $9.8 billion in Q4, up 9.9% reported and 6.6% organically; $36.4 billion for FY26, up 8.4% reported and 5.8% organically.Adjusted EPS: $1.55 for Q4 an

gurufocus.com - 2026-06-03 14:00:00

Medtronic just wrapped up its best year in a decade.

fool.com - 2026-06-03 13:57:08

Medtronic (MDT) shares are on the rise following a robust fiscal Q4 performance and an optimistic FY27 growth forecast. Although the company's full-year EPS gu

gurufocus.com - 2026-06-03 12:14:00

MDT tops Q4 revenue and earnings estimates as Cardiovascular strength and Cardiac Ablation growth fuel results, while FY27 guidance points higher.

zacks.com - 2026-06-03 11:46:19

Between JOLTS yesterday and ADP this morning, the labor market looks back on track.

zacks.com - 2026-06-03 11:40:54

While the top- and bottom-line numbers for Medtronic (MDT) give a sense of how the business performed in the quarter ended April 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com - 2026-06-03 10:30:20

Medtronic has undergone a business revamp and is now ready to grow again, including by leaning into acquisitions.

fool.com - 2026-06-03 09:44:01

Stock futures are sluggish after yesterday's record rally while unpack jobs data and Iran developments

schaeffersresearch.com - 2026-06-03 09:18:00

Medtronic NYSE: MDT reported what executives described as its strongest top-line performance in a decade, as growth in cardiac ablation, diabetes, medical-surgical products and select neuroscience platforms helped drive fiscal fourth-quarter and full-year results above expectations.

marketbeat.com - 2026-06-03 09:05:34

Medtronic (MDT) came out with quarterly earnings of $1.55 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $1.62 per share a year ago.

zacks.com - 2026-06-03 08:55:10

Microsoft announces AI tools and quantum chip, SpaceX reportedly decides IPO price, and more

fool.com - 2026-06-03 07:30:00

The medical device maker posts fiscal fourth-quarter earnings and revenue that narrowly beat analysts' estimates.

barrons.com - 2026-06-03 07:20:00

Medtronic said its profit and sales rose during its fiscal fourth quarter, reflecting steps the company has taken to improve business performance and drive growth.

wsj.com - 2026-06-03 07:19:00

Company also announces 510(k) pending for LigaSure™ RAS Maryland instrument on the Hugo RAS system, and 510(k) clearance for ProGrip™ Advanced self-gripping polypropylene mesh for use in robotic-assisted ventral hernia repair surgeries GALWAY, Ireland, June 3, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced significant milestones to unlock expanded indications for the Hugo™ robotic-assisted surgery (RAS) system in the United States and to shape the future of surgery. General surgery indication including hernia repair — 510(k) clearance submitted Embrace Gynecology Investigational Device Exemption (IDE) clinical study — completed enrollment Gynecologic surgery indication — 510(k) clearance submitted LigaSure™ RAS Maryland instrument — 510(k) clearance submitted ProGrip™ Advanced mesh for use in robotic-assisted ventral hernia repair — 510(k) clearance received These milestones build momentum for Medtronic's Surgical business and its purposeful launch of the Hugo RAS system, which received FDA clearance for urologic surgical procedures in December 2025 and is in commercial use at leading U.S. medical centers.

prnewswire.com - 2026-06-03 07:05:00

Investments in intracardiac echocardiography (ICE) technologies highlight Medtronic's commitment to driving durable growth in the cardiac ablation business through a differentiated portfolio of technologies GALWAY, Ireland, June 3, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced strategic investments in two privately held companies focused on the development of intracardiac echocardiography (ICE) catheter technologies. ICE catheters provide real-time, high-resolution imaging of the heart during electrophysiology (EP) procedures for cardiac arrhythmias such as atrial fibrillation (Afib).

prnewswire.com - 2026-06-03 06:55:00

Medtronic beat Wall Street estimates for fourth-quarter revenue and adjusted profit on Wednesday, riding the wave of steady ​demand for its heart devices used in complex cardiac ‌procedures.

reuters.com - 2026-06-03 06:50:33

GALWAY, Ireland, June 3, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced financial results for its fourth quarter (Q4) and fiscal year 2026 (FY26), which ended April 24, 2026.

prnewswire.com - 2026-06-03 06:45:00

Medtronic (MDT) to report Q4 2026 results on 6/3, expected revenue of $9.61B and EPS of $1.55. Recent acquisition of SPR Therapeutics adds to neuromodulation business. Analyst ratings show mixed opinions.

feeds.benzinga.com - 2026-06-03 03:54:13